Psoriasis alters HDL composition and cholesterol efflux capacity
about
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskPsoriasis and comorbid diseases: Epidemiology.HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Anti-psoriatic therapy recovers high-density lipoprotein composition and function.Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet.Aging affects high-density lipoprotein composition and function.High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.High-Density Lipoprotein Function in Exudative Age-Related Macular DegenerationA Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass SpectrometryCharacterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.Psoriasis: it's more than just the skin.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein functionProteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondUnraveling the complexities of the HDL lipidomeComparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins.Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasmaRefined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity.Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right directionAssessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis.Does treatment of psoriasis reduce the risk of cardiovascular disease?Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases.The role of high-density lipoproteins in the regulation of angiogenesis.Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.Psoriasis-associated vascular disease: the role of HDL.Liver disease alters high-density lipoprotein composition, metabolism and function.Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants.Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.Local effects of adipose tissue in psoriasis and psoriatic arthritis.Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease.
P2860
Q26775420-0D6358BF-309C-41E2-801D-0B5EBDABBB19Q30235889-62067956-80F5-4BF8-BF0F-512D3A1C4E21Q30251918-059A04D2-CE80-4F20-8E76-C9AE6F91F832Q34259215-485B7588-C586-4B14-8ED6-489B5088FC5CQ34684069-664329D2-B5B2-4241-A56F-7B06DE15AB04Q34781392-C617F88E-BF2E-4D27-B45A-42AF533FA3F4Q35802117-C8446798-C403-4BB6-A82C-E0F59B84555AQ36015473-8222689A-E8C2-4A43-8627-C32D676D8A9DQ36467197-0EF7C377-4C2E-4F8A-86F6-1EDB6478993EQ36514727-97E6EEBA-AF7C-4B8E-99C0-0A4F774327EFQ36520300-6E6F1EB1-B880-4AAA-BFC0-F8989E8513C7Q36681220-44FE15A5-F0BA-4C73-91FD-395732BBBE5EQ37162996-041EB302-C7AD-4118-9305-371C09452F91Q37222656-A2FCE6A1-4F5B-4305-8F32-A37C4D028A78Q37278677-9E21AE8E-112A-4F47-95B6-690D4915D7B9Q37441776-EEA09F9B-8C96-47C5-9C3D-7B5C376FD681Q37472192-1F182390-4E7D-486A-8594-AB1F7F693198Q37554151-3C6AFDF9-0C71-4582-B8FB-8B0F08F4E199Q37593287-A72E4B7E-F1D4-4F35-9B7F-1D1F21323485Q38111810-9015A1F4-0848-4414-AE2B-6DFDA8AFBAB0Q38118351-583B1F0A-DC96-4FA1-ABB5-838155AD998DQ38178202-20FC121F-1D17-44E8-A636-800CA3E4DADBQ38304297-C31D8E31-9CE7-4033-9314-DBBB661D9142Q38373133-ECC39F93-2672-4177-A64A-BD61FCE959EBQ40083837-C315A115-671D-4C94-9FB0-4D133F70ADCEQ41108229-371D3C29-C543-4B1B-82A5-A3BAC26CF7A5Q41231925-2C24142D-AFC7-421E-9825-F89D12F6AFC9Q41987920-7C1A2E8C-2011-4FC8-BA89-8306DB783963Q46180528-E9B6BF5F-254F-4ADA-8593-610B1D50CA7DQ47144623-4B976062-A797-4C5C-A8CD-86054FFF9342Q47390287-52C7E287-1B2B-4555-93AA-10A3F4FA7F42Q47429427-3B3E7276-067E-42D2-82EE-5AEEB99479D9Q50776527-2AC1DD65-5A75-4C4A-BA7E-ED5C6A9A619DQ54619049-184987CC-6354-4B7F-AC2B-BB2ECC757D2BQ55440359-09D44333-A994-4A8B-8756-0FC10DC4D465Q55515189-FFAA699F-0E72-4830-920F-D0D89C96D35F
P2860
Psoriasis alters HDL composition and cholesterol efflux capacity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Psoriasis alters HDL composition and cholesterol efflux capacity
@ast
Psoriasis alters HDL composition and cholesterol efflux capacity
@en
type
label
Psoriasis alters HDL composition and cholesterol efflux capacity
@ast
Psoriasis alters HDL composition and cholesterol efflux capacity
@en
prefLabel
Psoriasis alters HDL composition and cholesterol efflux capacity
@ast
Psoriasis alters HDL composition and cholesterol efflux capacity
@en
P2093
P2860
P50
P356
P1476
Psoriasis alters HDL composition and cholesterol efflux capacity
@en
P2093
Christian Wadsack
Dalia El-Gamal
Martin Inzinger
Peter Wolf
Sanja Curcic
Wolfgang Weger
P2860
P304
P356
10.1194/JLR.M027367
P577
2012-05-30T00:00:00Z